5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.24▲ | 0.24▼ | 0.25▼ | 0.27▼ | 0.24▲ |
MA10 | 0.24▼ | 0.25▼ | 0.25▼ | 0.25▼ | 0.28▼ |
MA20 | 0.25▼ | 0.25▼ | 0.27▼ | 0.23▲ | 0.32▼ |
MA50 | 0.26▼ | 0.27▼ | 0.26▼ | 0.28▼ | 0.84▼ |
MA100 | 0.26▼ | 0.26▼ | 0.25▼ | 0.32▼ | 2.96▼ |
MA200 | 0.28▼ | 0.27▼ | 0.29▼ | 0.66▼ | 19.31▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.000▼ | -0.004▼ | 0.007▲ | 0.043▲ |
RSI | 41.796▼ | 42.150▼ | 43.395▼ | 46.630▼ | 34.256▼ |
STOCH | 20.035 | 6.838▼ | 10.460▼ | 39.888 | 24.477 |
WILL %R | -81.818▼ | -96.226▼ | -94.444▼ | -84.593▼ | -70.947 |
CCI | -41.608 | -98.246 | -111.483▼ | 32.433 | -8.239 |
Friday, April 25, 2025 10:22 AM
Cyclacel Pharmaceuticals shares are trading higher by 77% during Friday's session. The company announced a securities purchase agreement with investor David Lazar.
|
Tuesday, April 08, 2025 05:00 PM
Get Cyclacel Pharmaceuticals alerts: Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) last issued its quarterly earnings results on Wednesday, April 2nd. The biotechnology company ...
|
Wednesday, April 02, 2025 09:05 AM
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.2627 | 0.294 | 0.241 | 0.243 | 1,853,881 |
30/04/25 | 0.2483 | 0.276 | 0.237 | 0.2582 | 4,764,393 |
29/04/25 | 0.2299 | 0.41 | 0.2299 | 0.2987 | 107,362,199 |
28/04/25 | 0.2986 | 0.4198 | 0.25 | 0.2853 | 10,980,510 |
25/04/25 | 0.234 | 0.30 | 0.2263 | 0.2785 | 3,745,845 |
24/04/25 | 0.2233 | 0.2394 | 0.2171 | 0.229 | 378,013 |
23/04/25 | 0.222 | 0.2347 | 0.2201 | 0.2302 | 578,758 |
22/04/25 | 0.225 | 0.23 | 0.211 | 0.2256 | 62,282 |
21/04/25 | 0.23 | 0.234 | 0.2108 | 0.2111 | 118,421 |
17/04/25 | 0.2108 | 0.2261 | 0.2108 | 0.2261 | 56,980 |
|
|
||||
|
|
||||
|
|